Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results for the Thirte

Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results for the Thirteen Months Period Ended March 31, 2017

ID: 543410

(firmenpresse) - LAVAL, QUEBEC -- (Marketwired) -- 05/18/17 -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ: NEPT)(TSX: NEPT), announces that it will be holding a conference call on June 7, 2017 at 5:00 PM (EST) to discuss its fourth quarter and fiscal year-end results for the thirteen months period ended March 31, 2017.

The fourth quarter results press release will be issued on the same day at 4:00 PM (EST).

Conference Call Details:

A replay of the call will be available for replay two hours after the call's completion, until July 7, 2017. The telephone numbers to access the replay of the call are 1 (416) 621-4642 or 1 (800) 585-8367 (toll-free), Conference ID 23766321. The archive of the webcast, along with its accompanying presentation, will also be made available immediately in the Investors section of Neptune's website under Investor Events and Presentations.

About Neptune Technologies & Bioressources Inc.

Neptune is a nutrition products company focused on the business of customized unique nutrition solutions, specialty ingredients and consumer brands. The company develops turnkey solutions available in various unique delivery forms. Neptune also offers premium krill oil manufactured in its state-of-the art facility and a variety of other specialty ingredients such as marine and seed oils. Neptune sells its premium krill oil under the OCEANO3® brand directly to consumers in Canada and the United States through web sales at . OCEANO3 is also sold as a turnkey solution to distributors. The Company's head office is located in Laval, Quebec.

Neptune is also pursuing opportunities in the prescription drug markets, through its approximately 34% owned subsidiary Acasti Pharma Inc. ("Acasti"). Acasti focuses on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of severe hypertriglyceridemia.

SOURCE: Neptune Technologies & Bioressources Inc.







Contacts:
Neptune Wellness Solutions
Mario Paradis
VP & CFO, Neptune
1.450.687.2262 x236


Investor Relations Contact (Canada)
Pierre Boucher
MaisonBrison
1.514.731.0000


Investor Relations Contact (U.S.)
James Carbonara
Hayden IR
1.646.755.4712

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Fortify Resources to Evaluate Medical Marijuana Opportunities MediXall Group, Inc. to Offer Financing Resources to MediXaid(R) Provider Network
Bereitgestellt von Benutzer: Marketwired
Datum: 18.05.2017 - 12:30 Uhr
Sprache: Deutsch
News-ID 543410
Anzahl Zeichen: 0

contact information:
Town:

LAVAL, QUEBEC



Kategorie:

Alternative



Diese Pressemitteilung wurde bisher 89 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal Year-End Results for the Thirteen Months Period Ended March 31, 2017"
steht unter der journalistisch-redaktionellen Verantwortung von

Neptune Technologies & Bioressources Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Neptune Announces Second Quarter Results ...

LAVAL, QUEBEC -- (Marketwired) -- 11/14/17 -- Q2 Financial and Operational Highlights for the 3-month period ended September 30, 2017 compared to the 3-month period ended August 31, 2016(1)Post Quarter End Highlights:Neptune Technologies & Biore ...

Alle Meldungen von Neptune Technologies & Bioressources Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z